A Myocardial Infarction, commonly known as a heart attack, is a life-threatening event that occurs when the heart does not ...

Myocardial infarction remains one of the leading causes of death worldwide. Following an infarction, part of the heart muscle ...

Recently published Acute Myocardial Infarction Market Insights report includes a comprehensive understanding of current treatment practices, acute myocardial infarction emerging drugs, market share of ...

Emerging research reveals that even undiagnosed, or 'silent,' heart attacks can accelerate cognitive decline and increase the ...

Even undiagnosed heart attacks, or silent myocardial infarctions, can speed up cognitive decline, according to the findings ...

BACKGROUND: The optimal transfusion strategy in patients with acute myocardial infarction (AMI) and anemia may be influenced by sex differences in pathophysiology and cardiovascular outcomes. The ...

The elderly account for the majority of medical spending in many countries, raising concerns about potentially unnecessary spending, especially during the final months of life. Using a well-defined ...

Despite the high rate of sudden death after myocardial infarction among patients with a low ejection fraction, implantable cardioverter–defibrillators are contraindicated until 40 to 90 days after ...

We have previously demonstrated an association between combination antiretroviral therapy and the risk of myocardial infarction. It is not clear whether this association differs according to the class ...

The acute myocardial infarction market is experiencing steady growth driven by rising global cardiovascular disease prevalence and expanding geriatric populations. Advances in diagnostic technologies ...